Staphylococcus aureus Leukocidin A/B (LukAB) Kills Human Monocytes via Host NLRP3 and ASC when Extracellular, but Not...

Area of Science:

• Microbiology
• Immunology
• Cell Biology

Background:

• Staphylococcus aureus infections pose a significant global health threat.
• Bacterial virulence factors, such as pore-forming leukotoxins, are key to S. aureus pathogenesis.
• Leukocidin A/B (LukAB) is a recently identified toxin that eliminates human phagocytes, but its mechanism remains unclear.

Purpose of the Study:

• To elucidate the mechanism by which LukAB induces cell death in human monocytes.
• To investigate the role of LukAB in S. aureus-mediated monocyte killing.
• To explore the differential host responses to LukAB based on cellular contact site.

Main Methods:

• Utilized in vitro and ex vivo intoxication and infection models with human monocytes and THP1 cells.
• Assessed Caspase 1 activation, IL-1β secretion, and cell death (necrosis).
• Investigated the requirement for inflammasome components (NLRP3, ASC) and the receptor CD11b.

Main Results:

• LukAB activates Caspase 1, promotes IL-1β secretion, and induces necrosis in human monocytes.
• NLRP3 and ASC are essential for LukAB-mediated IL-1β secretion and necrosis from extracellular S. aureus.
• LukAB-mediated killing of phagocytosed S. aureus is independent of ASC and NLRP3 but requires CD11b.

Conclusions:

• LukAB is a major factor in S. aureus-induced human monocyte death.
• Host response to LukAB differs based on whether S. aureus is extracellular or intracellular.
• Understanding these differential responses is vital for developing targeted anti-infective and anti-inflammatory therapies, particularly those targeting the NLRP3 inflammasome.